5 terminated, 2 completed, 1 active not recruiting, 1 recruiting. 9 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Terminated 5, Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow ITB-Med LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TCD601 in de Novo Renal Transplant Recipients TCD601, belatacept, ATG - Renal Transplantation | Phase 2 | Completed | ITB-Med LLC | 76 | 2023-12-28 | 2026-05-05 |
| Delayed Tolerance Through Mixed Chimerism Bone Marrow Transplant, Peripheral Blood Stem Cell Collection, Fludarabine - Kidney Failure, Kidney Transplant; Complications | Phase 1 / Phase 2 | Recruiting | Massachusetts General Hospital | 20 | 2023-10-01 | 2026-09-28 |
| Siplizumab for Sickle Cell Disease Transplant Siplizumab, Exchange Transfusion, Total Body Irradiation - Anemia, Sickle Cell | Phase 1 / Phase 2 | Terminated | Columbia University | 1 | 2023-09-28 | 2026-06-10 |
| A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients TCD601, Placebo - Diabetes Mellitus, Type 1 | Phase 2 | Terminated | ITB-Med LLC | 9 | 2023-01-23 | 2025-08-14 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) TCD601 - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 4 | 2023-01-17 | 2026-11-04 |
| A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) TCD601 - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 7 | 2022-12-14 | 2026-07-13 |
| A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation TCD601, Cyclophosphamide, TAC - Liver Transplantation | Phase 2 | Active not recruiting | ITB-Med LLC | 12 | 2022-06-29 | 2024-11-27 |
| A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Terminated | ITB-Med LLC | 33 | 2021-06-06 | 2026-03-12 |
| A Dose Escalation Study in de Novo Renal Transplantation TCD601, Tacrolimus (TAC), Corticosteroids (CS) - Kidney Transplantation | Phase 2 | Completed | ITB-Med LLC | 13 | 2021-05-26 | 2025-02-27 |
Anemia, Sickle Cell (1) · Diabetes Mellitus, Type 1 (1) · Disease (1) · Renal Insufficiency (1) · Sickle Cell Trait (1)
siplizumab (5) · Adrenal Cortex Hormones (4) · Mycophenolic Acid (4) · Tacrolimus (4) · Cyclophosphamide (3) · Rituximab (2) · Abatacept (1) · Antilymphocyte Serum (1) · Biosimilar Pharmaceuticals (1) · Bone Marrow Transplantation (1) · Exchange Transfusion, Whole Blood (1) · Mesna (1) · Sirolimus (1) · Whole-Body Irradiation (1) · fludarabine (1)
United States (6) · Sweden (3) · Spain (2) · Austria (1) · Belgium (1) · Italy (1) · South Korea (1) · United Kingdom (1)
Fredrik Juhlin (3) · Tracy Killingsworth (2) · Kellie Kennon, BSN (1) · Markus Y Mapara, MD, PhD (1) · Nick Hryciw, MA (1) · Tatsuo Kawai (1)